authors
- Flaker, Greg
- Ezekowitz, Michael
- Yusuf, Salim
- Wallentin, Lars
- Noack, Herbert
- Brueckmann, Martina
- Reilly, Paul
- Hohnloser, Stefan H
- Connolly, Stuart
Efficacy and Safety of Dabigatran Compared to Warfarin in Patients With Paroxysmal, Persistent, and Permanent Atrial Fibrillation
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- February 2012
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1117 Public Health and Health Services (FoR)
- Anticoagulants (MeSH)
- Atrial Fibrillation (MeSH)
- Benzimidazoles (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Dabigatran (MeSH)
- Dose-Response Relationship, Drug (MeSH)
- Electrocardiography (MeSH)
- Embolism (MeSH)
- Female (MeSH)
- Follow-Up Studies (MeSH)
- Heart Rate (MeSH)
- Humans (MeSH)
- Male (MeSH)
- Randomized Controlled Trials as Topic (MeSH)
- Stroke (MeSH)
- Tachycardia, Paroxysmal (MeSH)
- Time Factors (MeSH)
- Treatment Outcome (MeSH)
- Warfarin (MeSH)
- beta-Alanine (MeSH)